Skip to main content
Top
Published in: Internal and Emergency Medicine 2/2023

Open Access 13-01-2023 | Internal Medicine | Ce-research Letter to the Editor

Effects of COVID-19 vaccination on clinical outcomes in patients hospitalized in Internal Medicine during Omicron variant spreading.

Authors: Luca Colangeli, Gianna Aprile, Clara Carcone, Monica D’Adamo, Emanuela Medda, Paolo Sbraccia, Valeria Guglielmi

Published in: Internal and Emergency Medicine | Issue 2/2023

Login to get access

Excerpt

Dear Editor, …
Literature
1.
go back to reference Polack FP et al (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383(27):2603–2615CrossRefPubMed Polack FP et al (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383(27):2603–2615CrossRefPubMed
2.
go back to reference Baden LR et al (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384(5):403–416CrossRefPubMed Baden LR et al (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384(5):403–416CrossRefPubMed
3.
go back to reference Sadoff J et al (2021) Safety and efficacy of single-dose ad26cov2s vaccine against covid-19. N Engl J Med 384(23):2187–2201CrossRefPubMed Sadoff J et al (2021) Safety and efficacy of single-dose ad26cov2s vaccine against covid-19. N Engl J Med 384(23):2187–2201CrossRefPubMed
4.
go back to reference Dunkle LM et al (2022) Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico. N Engl J Med 386(6):531–543CrossRefPubMed Dunkle LM et al (2022) Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico. N Engl J Med 386(6):531–543CrossRefPubMed
5.
go back to reference Mohsin M, Mahmud S (2022) Omicron SARS-CoV-2 variant of concern: a review on its transmissibility, immune evasion, reinfection, and severity. Medicine 101(19):e29165CrossRefPubMedPubMedCentral Mohsin M, Mahmud S (2022) Omicron SARS-CoV-2 variant of concern: a review on its transmissibility, immune evasion, reinfection, and severity. Medicine 101(19):e29165CrossRefPubMedPubMedCentral
6.
go back to reference Barouch DH (2022) Covid-19 vaccines - immunity, variants Boosters. N Engl J Med 387(11):1011–1020CrossRefPubMed Barouch DH (2022) Covid-19 vaccines - immunity, variants Boosters. N Engl J Med 387(11):1011–1020CrossRefPubMed
7.
9.
go back to reference Corradini E et al (2021) Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI). Intern Emerg Med 16(4):1005–1015CrossRefPubMedPubMedCentral Corradini E et al (2021) Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI). Intern Emerg Med 16(4):1005–1015CrossRefPubMedPubMedCentral
10.
go back to reference Guglielmi V et al (2022) Inflammation, underweight, malignancy and a marked catabolic state as predictors for worse outcomes in COVID-19 patients with moderate-to-severe disease admitted to internal medicine unit. PLoS One 17(5):e0268432CrossRefPubMedPubMedCentral Guglielmi V et al (2022) Inflammation, underweight, malignancy and a marked catabolic state as predictors for worse outcomes in COVID-19 patients with moderate-to-severe disease admitted to internal medicine unit. PLoS One 17(5):e0268432CrossRefPubMedPubMedCentral
13.
go back to reference Razonable RR et al (2022) Real-world clinical outcomes of bebtelovimab and sotrovimab treatment of high-risk persons with coronavirus disease 2019 during the omicron epoch. Open Forum Infect Dis 9(10):411CrossRef Razonable RR et al (2022) Real-world clinical outcomes of bebtelovimab and sotrovimab treatment of high-risk persons with coronavirus disease 2019 during the omicron epoch. Open Forum Infect Dis 9(10):411CrossRef
14.
go back to reference Ghazanfar H et al (2022) Outcomes of monoclonal antibody infusion treatment during delta (B16172) and omicron (B11529) COVID 19 variant surges among vaccinated and unvaccinated patients. Health Serv Insights 15:11786329221127152PubMedPubMedCentral Ghazanfar H et al (2022) Outcomes of monoclonal antibody infusion treatment during delta (B16172) and omicron (B11529) COVID 19 variant surges among vaccinated and unvaccinated patients. Health Serv Insights 15:11786329221127152PubMedPubMedCentral
15.
go back to reference Ward IL et al (2022) Risk of covid-19 related deaths for SARS-CoV-2 omicron (B1.1.529) compared with delta (B.1.617.2): retrospective cohort study. Bmj. 378:e070695CrossRefPubMed Ward IL et al (2022) Risk of covid-19 related deaths for SARS-CoV-2 omicron (B1.1.529) compared with delta (B.1.617.2): retrospective cohort study. Bmj. 378:e070695CrossRefPubMed
Metadata
Title
Effects of COVID-19 vaccination on clinical outcomes in patients hospitalized in Internal Medicine during Omicron variant spreading.
Authors
Luca Colangeli
Gianna Aprile
Clara Carcone
Monica D’Adamo
Emanuela Medda
Paolo Sbraccia
Valeria Guglielmi
Publication date
13-01-2023
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 2/2023
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-022-03185-5

Other articles of this Issue 2/2023

Internal and Emergency Medicine 2/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.